αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies

Clinical trial NCT02151448 · COMPLETED

Trial details

NCT number: NCT02151448
Sponsor: David Bartlett
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface Malignant Peritoneal Mesothelioma Peritoneal Carcinomatosis

Start date: 2014-07-01
Primary completion: 2019-02-18
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.